Ehlers-Danlos Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Condition: Vascular Ehlers-Danlos Syndrome Interventions: Drug: ACER-002 (celiprolol) 200 mg BID; Drug: Placebo BID Sponsor: Acer Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2022 Category: Research Source Type: clinical trials

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Condition: Vascular Ehlers-Danlos Syndrome Interventions: Drug: ACER-002 (celiprolol) 200 mg BID; Drug: Placebo BID Sponsor: Acer Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2022 Category: Research Source Type: clinical trials

Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
Conditions: Ehlers-Danlos Syndrome; Classical Ehlers-Danlos Syndrome; Hypermobile EDS (hEDS) Intervention: Other: Skin Biopsy Sponsor: University Health Network, Toronto Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2022 Category: Research Source Type: clinical trials